CYTX Financial Facts
General and administrative: 1.94MTotal product revenues: 1.47M
See Full Income Statement
Deferred revenues: 97K
Restricted cash and cash equivalents: 0
See Full Balance Sheet
Cytori Therapeutics (CYTX) Earnings
|
Expand Research on CYTX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/1/19 |  |
Q418 | -$0.20 | -$0.30 | +$0.10 | $376K | $1.89M | N/A |  | | Details |
| 11/14/18 | |
Q318 | -$0.27 | -$0.30 | +$0.03 | N/A | $1.89M | N/A | | | Details |
| 8/14/18 | |
Q218 | -$0.59 | -$0.45 | -$0.14 | N/A | $1.86M | N/A | | | Details |
| 5/10/18 | |
Q118 | -$0.07 | -$0.06 | -$0.01 | $1.6M | $2.74M | = | | | Details |
| 3/8/18 | |
Q417 | -$0.10 | -$0.06 | -$0.04 | $1.5M | $2.74M | = | | | Details |
| 11/9/17 | |
Q317 | -$0.14 | -$0.13 | -$0.01 | $1.8M | $2.5M | = | | | Details |
| 8/10/17 | |
Q217 | -$0.19 | -$0.21 | +$0.02 | $1.5M | $2.23M | = | | | Details |
| 5/11/17 | |
Q117 | -$0.26 | -$0.28 | +$0.02 | $1.6M | $2.57M | = | | | Details |
